"The Heart Asks Pleasure First"-Conceptualizing Psychiatric Diseases as MAINTENANCE Network Dysfunctions through Insights from slMFB DBS in Depression and Obsessive-Compulsive Disorder.
Volker Arnd CoenenThomas E SchlaepferBastian E A SajonzPeter C ReinacherMáté D DöbrössyMarco ReisertPublished in: Brain sciences (2022)
More than a decade ago, deep brain stimulation (DBS) of the superolateral medial forebrain bundle (slMFB), as part of the greater MFB system, had been proposed as a putative yet experimental treatment strategy for therapy refractory depression (TRD) and later for obsessive-compulsive disorders (OCD). Antidepressant and anti-OCD efficacy have been shown in open case series and smaller trials and were independently replicated. The MFB is anato-physiologically confluent with the SEEKING system promoting euphoric drive, reward anticipation and reward; functions realized through the mesocorticolimbic dopaminergic system. Growing clinical experience concerning surgical and stimulation aspects from a larger number of patients shows an MFB functionality beyond SEEKING and now re-informs the scientific rationale concerning the MFB's (patho-) physiology. In this white paper, we combine observations from more than 75 cases of slMFB DBS. We integrate these observations with a selected literature review to provide a new neuroethological view on the MFB. We here formulate a re-interpretation of the MFB as the main structure of an integrated SEEKING/MAINTENANCE circuitry, allowing for individual homeostasis and well-being through emotional arousal, basic and higher affect valence, bodily reactions, motor programing, vigor and flexible behavior, as the basis for the antidepressant and anti-OCD efficacy.
Keyphrases
- obsessive compulsive disorder
- deep brain stimulation
- parkinson disease
- mental health
- major depressive disorder
- end stage renal disease
- depressive symptoms
- newly diagnosed
- ejection fraction
- heart failure
- chronic kidney disease
- sleep quality
- minimally invasive
- clinical trial
- prognostic factors
- case report
- patient reported outcomes
- mesenchymal stem cells
- bone marrow
- patient reported
- cell therapy
- replacement therapy